GoodRx reports that the FDA has approved oral semaglutide (Wegovy) for weight loss, offering an alternative to injections ...

Glucagon-like peptide-1 (GLP-1) medications are now available as a pill for weight loss, offering another option beyond ...

If you've been following the weight-loss medication revolution, you've likely heard about Wegovy injections. But now there's ...

In a clinical trial, this small-molecule drug was found to be superior to semaglutide for lowering blood sugar.

Structure Therapeutics said its GLP-1 pill helped patients lose more than 16% of their body weight in a midstage trial, ...

U.S. Food and Drug Administration (FDA) approved Wegovy pill from Novo Nordisk. The pill will contain 25 mg of ...

Testing revealed weight loss effects some Wall Street analysts believe compare favorably to Lilly’s orforglipron, which ...

One pill for obesity is already on the market, and more are on the way. But the injected drugs have key advantages.

About 10 weeks after it was approved, the Wegovy pill is now estimated to be part of the daily regimen of about 400,000 ...

Structure Therapeutics’ oral obesity drug elicited a placebo-adjusted weight loss of 16.3% at 44 weeks in a Phase 2 trial.

Structure Therapeutics Inc.’s shares rose after more data on the company’s experimental weight-loss pill showed it’s shaping ...

As obesity levels in Britain soars new research has confirmed that some people carry the FTO "fat" gene. According to research published in Nature Genetics those with the gene could suffer from ...